...
首页> 外文期刊>Frontiers in Neurology >Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington’s Disease
【24h】

Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington’s Disease

机译:遗传学调制灰质变异以超越疾病负担在前驱亨廷顿氏病

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Huntington’s disease (HD) is a neurodegenerative disorder caused by an expansion mutation of the cytosine–adenine–guanine (CAG) trinucleotide in the HTT gene. Decline in cognitive and motor functioning during the prodromal phase has been reported, and understanding genetic influences on prodromal disease progression beyond CAG will benefit intervention therapies. From a prodromal HD cohort ( N ?=?715), we extracted gray matter (GM) components through independent component analysis and tested them for associations with cognitive and motor functioning that cannot be accounted for by CAG-induced disease burden (cumulative effects of CAG expansion and age). Furthermore, we examined genetic associations (at the genomic, HD pathway, and candidate region levels) with the GM components that were related to functional decline. After accounting for disease burden, GM in a component containing cuneus, lingual, and middle occipital regions was positively associated with attention and working memory performance, and the effect size was about a tenth of that of disease burden. Prodromal participants with at least one dystonia sign also had significantly lower GM volume in a bilateral inferior parietal component than participants without dystonia, after controlling for the disease burden. Two single-nucleotide polymorphisms (SNPs: rs71358386 in NCOR1 and rs71358386 in ADORA2B) in the HD pathway were significantly associated with GM volume in the cuneus component, with minor alleles being linked to reduced GM volume. Additionally, homozygous minor allele carriers of SNPs in a candidate region of ch15q13.3 had significantly higher GM volume in the inferior parietal component, and one minor allele copy was associated with a total motor score decrease of 0.14?U. Our findings depict an early genetical GM reduction in prodromal HD that occurs irrespective of disease burden and affects regions important for cognitive and motor functioning.
机译:亨廷顿的疾病(HD)是由HTT基因中胞嘧啶 - 腺嘌呤(CAG)三核苷酸的膨胀突变引起的神经变性疾病。报道了前阶段期间认知和运动功能的下降,并了解超越CAG的前驱疾病进展的遗传影响将受益于干预疗法。从前驱高清队(n?=α715),我们通过独立的分量分析提取灰质(GM)组分,并对与认知和电机功能的关联进行测试,不能通过CAG诱导的疾病负担来计算(累积效果) CAG扩张和年龄)。此外,我们检查了与功能下降相关的GM组分的遗传关联(在基因组,高清途径和候选区域水平上)。在核算疾病负担后,GM在包含诅咒,语言和中部枕部地区的组件中与关注和工作记忆性能有关,效果大约大约是疾病负担的十分之一。在控制疾病负担之后,具有至少一种肌瘤符号的前期下垂组分中,至少有一个肌瘤症的患者在双侧较低的前视性组分中显着降低了GM体积。 HD途径中的两个单核苷酸多态性(NCOR1和NCOR1和RS71358386中的NCOR1和RS71358386)与Cuneus组分的GM体积显着相关,细微等位基因与降低的通用群体有关。另外,CH15Q13.3候选区域中SNP的纯合的次次等位基因载体在下间成分中具有显着高的GM体积,并且一个次要的等位基因拷贝与总电机得分减少0.14?U相关。我们的研究结果描绘了一种早期的生殖转基因,其出现的产物HD,而不管疾病负担如何,影响对认知和运动功能都很重要的区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号